Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Companion Diagnostics

Thomas Li's Biography



Thomas Li, Chief Technology Officer, A*STAR Singapore

Thomas M. Li, Ph.D. is the Chief Technology Officer of the Diagnostics and Devices Hub at A*STAR in Singapore. He was the Senior Director, Chief Technology Office at Roche in USA and Head of Asia Pacific Technology Management at Roche in Singapore and was the former Director of Diagnostics at Invitrogen Corporation in Carlsbad, California. Dr. Li received his Ph.D in Biophysical Chemistry from the University of Illinois in Urbana-Champaign and completed his post-doctoral fellowship at the Fox Chase Cancer Center in Philadelphia. Dr. Li is a member of ASCO and AACR, a Fellow of the American Academy of Allergy, Asthma and Immunology, a Fellow of the National Academy of Clinical Biochemistry and a Diplomat of the European Academy of Allergology and Clinical Immunology. He has published extensively in peer-reviewed journals and US patents, as well as contributing many oral presentations, invited papers and book chapters.

Thomas Li Image

The Diagnostics Journeys of Companion Dx Product Commercialization: The DxD Hub Perspectives

Monday, 27 October 2014 at 14:15

Add to Calendar ▼2014-10-27 14:15:002014-10-27 15:15:00Europe/LondonThe Diagnostics Journeys of Companion Dx Product Commercialization: The DxD Hub PerspectivesSELECTBIOenquiries@selectbiosciences.com

The objective of this presentation is to provide an update on the current status of the Diagnostics Development Hub in Singapore. We will describe the DxD Hub product development process. Within the Hub, we have devised a score card system to allow project entry into the Hub. The presentation will first highlight, the micro RNA technology journey, the biomarker panel development journey with the five levels of evidence for biomarker maturity. For companion diagnostics, another aspect of the diagnostics journey of co-development timeline in conjunction with the phase 1, 2 and 3 of drug clinical development will also be discussed. Finally, the regulatory journey of introducing a new diagnostics test into clinical practice and the oncology and heart failure patient care journey towards a personalized healthcare will also be presented.


Add to Calendar ▼2014-10-27 00:00:002014-10-28 00:00:00Europe/LondonCompanion DiagnosticsSELECTBIOenquiries@selectbiosciences.com